The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells.

International journal of oncology

Volumn 26, Issue 2, 2005, Pages 423-429

  Lareef, Mohamed H ^a   Garber, James ^a   Russo, Patricia A ^a   Russo, Irma H ^a   Heulings, Rebecca ^a   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL 17 BETA; 4-HYDROXYESTRADIOL-17 BETA; AGAR; COLLAGEN; DRUG DERIVATIVE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LAMININ; MATRIGEL; PROTEOGLYCAN;

ARTICLE; BREAST; CANCER INVASION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG COMBINATION; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; METABOLISM; PHENOTYPE; TUMOR CELL LINE;

AGAR; BREAST; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; HUMANS; LAMININ; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEOGLYCANS;

EID: 22344433095     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)